NCT00700284View on ClinicalTrials.gov

Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine)

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions
HIV Infections
Interventions
DRUG

placebo vaginal ring

vaginal ring containing no TMC120 (dapivirine)

DRUG

TMC120 (dapivirine) vaginal ring

vaginal ring containing 120 mg TMC120 (dapivirine)

Trial Locations (1)

9000

Drug Research Unit, UZ Gent, Ghent

All Listed Sponsors
collaborator

Tibotec Pharmaceutical Limited

INDUSTRY

lead

International Partnership for Microbicides, Inc.

INDUSTRY

NCT00700284 - Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine) | Biotech Hunter | Biotech Hunter